← back to search
Marina Nguenang
Université Claude Bernard Lyon 1
· FR
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Internal medicine, Lung cancer, Hazard ratio, KRAS, and Nivolumab.
h-index
—
citations
197
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer
Lung Cancer
2019
cited by
171
position: middle
doi
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
ERJ Open Research
2018
cited by
26
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Marie Wislez
· Institut National du Cancer
1
papers (2018–2018)
V. Gounant
· Université Claude Bernard Lyon 1
1
papers (2019–2019)
Ludovic Doucet
· Assistance Publique – Hôpitaux de Paris
1
papers (2018–2018)
—
·
1
papers (2018–2018)
—
·
1
papers (2018–2018)
Boris Duchemann
· Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
1
papers (2018–2018)
Baptiste Abbar
· Université Claude Bernard Lyon 1
1
papers (2019–2019)
Antoine Khalil
· Université Claude Bernard Lyon 1
1
papers (2019–2019)
—
·
1
papers (2018–2018)
Céline Namour
· Université Claude Bernard Lyon 1
1
papers (2019–2019)
Solenn Brosseau
· Université Claude Bernard Lyon 1
1
papers (2019–2019)
Johan Pluvy
· Université Claude Bernard Lyon 1
1
papers (2019–2019)
Jacques Cadranel
· Sorbonne Université
1
papers (2018–2018)
Sandra Assoun
· Université Claude Bernard Lyon 1
1
papers (2019–2019)
—
·
1
papers (2018–2018)
C. Chouaïd
· Institut Mondor de Recherche Biomédicale
1
papers (2018–2018)
Jean Trédaniel
· Toxicologie, Pharmacologie et Signalisation Cellulaire
1
papers (2018–2018)
Claire Danel
· Université Claude Bernard Lyon 1
1
papers (2019–2019)
Etienne Giroux‐Leprieur
· Inserm
1
papers (2018–2018)
S. Friard
· Hôpital Foch
1
papers (2018–2018)